Diferencia entre revisiones de «EBQ:MATTERs Study»
Sin resumen de edición |
|||
| Línea 56: | Línea 56: | ||
==Further Reading== | ==Further Reading== | ||
[[EBQ:CRASH-2_Trial]] | [[EBQ:CRASH-2_Trial | CRASH-2 Trial]] | ||
==Sources== | ==Sources== | ||
Revisión del 17:17 10 mar 2014
Under Review Journal Club Article
Morrison J. et al. "Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study". JAMA Surgery. 2012. 147(2):113-119.
PubMed Full text PDF
PubMed Full text PDF
Clinical Question
Does administration of Tranexamic (TXA) acid in trauma patients with hemorrhage improve mortality in a wartime setting?
Conclusion
The use of TXA with blood component-based resuscitation following combat injury results in improved measures of coagulopathy and survival, a benefit that is most prominent in patients requiring massive transfusion